127 related articles for article (PubMed ID: 9929057)
1. Adjuvant therapy of cutaneous melanoma.
Ascierto PA; Palmieri G
Lancet; 1999 Jan; 353(9149):328. PubMed ID: 9929057
[No Abstract] [Full Text] [Related]
2. [Adjuvant interferon therapy in malignant melanoma].
Mohr P
J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
[No Abstract] [Full Text] [Related]
3. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
4. [Adjuvant interferon treatment of melanoma].
Török L
Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant interferon in melanoma: is duration of therapy important?
McArthur GA
J Clin Oncol; 2014 Jan; 32(3):171-3. PubMed ID: 24344216
[No Abstract] [Full Text] [Related]
6. Adjuvant high-dose interferon therapy for melanoma: nothing has really changed.
Sanchez-Muñoz A; Navarro-Perez V; Alonso L; Moreno I; Alba E
Melanoma Res; 2014 Oct; 24(5):522-3. PubMed ID: 25185694
[No Abstract] [Full Text] [Related]
7. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
8. Duration of high-dose interferon alpha-2b regimen for resected high-risk melanoma.
Agarwala SS; Gray RJ; Wong MK
J Clin Oncol; 2009 Sep; 27(25):e82-3; author reply e84. PubMed ID: 19635995
[No Abstract] [Full Text] [Related]
9. Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J;
Acta Oncol; 2013 Aug; 52(6):1086-93. PubMed ID: 23621752
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant interferon in melanoma - a resurrection?
Middleton MR; Thatcher N
Br J Cancer; 2001 May; 84(9):1141-2. PubMed ID: 11336461
[No Abstract] [Full Text] [Related]
11. Adjuvant therapy of melanoma.
Geskin L; Brown CR; Kirkwood JM
Semin Cutan Med Surg; 2003 Mar; 22(1):55-67. PubMed ID: 12773014
[No Abstract] [Full Text] [Related]
12. Long-term outcomes and prognostic factors of high-risk malignant melanoma patients after surgery and adjuvant high-dose interferon treatment: a single-center experience.
Akman T; Oztop I; Unek IT; Koca D; Unal OU; Salman T; Yavuzsen T; Yilmaz AU; Somali I; Demir N; Ellidokuz H
Chemotherapy; 2014; 60(4):228-38. PubMed ID: 25870939
[TBL] [Abstract][Full Text] [Related]
13. The use of interferon alfa as adjuvant therapy for advanced cutaneous melanoma: the need for more evidence.
Kimyai-Asadi A; Usman A
J Am Acad Dermatol; 2000 Oct; 43(4):708-11. PubMed ID: 11004636
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
15. Is there a standard for the palliative treatment of melanoma?
Schadendorf D
Onkologie; 2002 Feb; 25(1):74-6. PubMed ID: 11928697
[No Abstract] [Full Text] [Related]
16. [Guidelines for proper use of antineoplastic agents. Skin cancer].
Uhara H; Saida T
Gan To Kagaku Ryoho; 2002 Jun; 29(6):1074-80. PubMed ID: 12109448
[No Abstract] [Full Text] [Related]
17. [Ocular complications of adjuvant interferon therapy for malignant melanoma: a review].
Ockenfels M; Lisch W
Hautarzt; 2003 Feb; 54(2):144-7. PubMed ID: 12590309
[TBL] [Abstract][Full Text] [Related]
18. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
19. Current therapy of cutaneous melanoma.
Mays SR; Nelson BR
Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
[TBL] [Abstract][Full Text] [Related]
20. Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
Trefzer U; Sterry W
Dermatology; 2005; 211(4):370-1. PubMed ID: 16286751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
